(Q54550048)

31 May 2018

title

Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes. (English)

1 reference

31 May 2018

author

Cathy B Moelans

2

1 reference

31 May 2018

Zsuzsanna Varga

1

object named as

Zsuzsanna Varga

1 reference

31 May 2018

Holger Moch

7

object named as

Holger Moch

1 reference

31 May 2018

author name string

Ursina Zuerrer-Hardi

3

1 reference

31 May 2018

Constanze Ramach

4

1 reference

31 May 2018

Silvia Behnke

5

1 reference

31 May 2018

Glen Kristiansen

6

1 reference

31 May 2018

language of work or name

English

0 references

publication date

15 November 2011

1 reference

31 May 2018

Breast Cancer Research and Treatment

published in

1 reference

31 May 2018

volume

133

1 reference

31 May 2018

issue

3

1 reference

31 May 2018

page(s)

929-935

1 reference

31 May 2018

Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Gene copy mapping of the ERBB2/TOP2A region in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil:

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Aberrations of ERBB2 and TOP2A genes in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

10.1007/S10549-011-1873-8

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018